BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26649621)

  • 1. Endometrial Expression of Estrogen Receptors and the Androgen Receptor in Women With Polycystic Ovary Syndrome: A Lifestyle Intervention Study.
    Hulchiy M; Nybacka Å; Sahlin L; Hirschberg AL
    J Clin Endocrinol Metab; 2016 Feb; 101(2):561-71. PubMed ID: 26649621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.
    Villavicencio A; Bacallao K; Avellaira C; Gabler F; Fuentes A; Vega M
    Gynecol Oncol; 2006 Oct; 103(1):307-14. PubMed ID: 16677694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of GPR30, ERα and ERβ in endometrium during window of implantation in patients with polycystic ovary syndrome: a pilot study.
    Wang A; Ji L; Shang W; Li M; Chen L; White RE; Han G
    Gynecol Endocrinol; 2011 Apr; 27(4):251-5. PubMed ID: 21269226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium.
    Gregory CW; Wilson EM; Apparao KB; Lininger RA; Meyer WR; Kowalik A; Fritz MA; Lessey BA
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2960-6. PubMed ID: 12050280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor alpha and beta expression in theca and granulosa cells from women with polycystic ovary syndrome.
    Jakimiuk AJ; Weitsman SR; Yen HW; Bogusiewicz M; Magoffin DA
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5532-8. PubMed ID: 12466349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome.
    Maliqueo M; Clementi M; Gabler F; Johnson MC; Palomino A; Sir-Petermann T; Vega M
    Fertil Steril; 2003 Sep; 80 Suppl 2():812-9. PubMed ID: 14505758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome.
    Nybacka Å; Carlström K; Ståhle A; Nyrén S; Hellström PM; Hirschberg AL
    Fertil Steril; 2011 Dec; 96(6):1508-13. PubMed ID: 21962963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome.
    Apparao KB; Lovely LP; Gui Y; Lininger RA; Lessey BA
    Biol Reprod; 2002 Feb; 66(2):297-304. PubMed ID: 11804942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC1 as a discriminator between endometrium from fertile and infertile patients with PCOS and endometriosis.
    Margarit L; Taylor A; Roberts MH; Hopkins L; Davies C; Brenton AG; Conlan RS; Bunkheila A; Joels L; White JO; Gonzalez D
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5320-9. PubMed ID: 20826587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.
    Thomson RL; Buckley JD; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3373-80. PubMed ID: 18583464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor beta and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis.
    Hudelist G; Keckstein J; Czerwenka K; Lass H; Walter I; Auer M; Wieser F; Wenzl R; Kubista E; Singer CF
    Fertil Steril; 2005 Oct; 84 Suppl 2():1249-56. PubMed ID: 16210018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome.
    Quezada S; Avellaira C; Johnson MC; Gabler F; Fuentes A; Vega M
    Fertil Steril; 2006 Apr; 85(4):1017-26. PubMed ID: 16580389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased 5 alpha-reductase activity and adrenocortical drive in women with polycystic ovary syndrome.
    Vassiliadi DA; Barber TM; Hughes BA; McCarthy MI; Wass JA; Franks S; Nightingale P; Tomlinson JW; Arlt W; Stewart PM
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3558-66. PubMed ID: 19567518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High serum concentration of total inhibin in polycystic ovary syndrome.
    Tsigkou A; Luisi S; De Leo V; Patton L; Gambineri A; Reis FM; Pasquali R; Petraglia F
    Fertil Steril; 2008 Nov; 90(5):1859-63. PubMed ID: 18423626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.
    Huber-Buchholz MM; Carey DG; Norman RJ
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1470-4. PubMed ID: 10199797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of estrogen receptor mRNA in human endometrium throughout the menstrual cycle using a real-time reverse transcription-polymerase chain reaction assay.
    Witek A; Mazurek U; Paul M; Bierzyńska-Macyszyn G; Wilczok T
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():116-8. PubMed ID: 11820566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clomiphene citrate versus letrozole: molecular analysis of the endometrium in women with polycystic ovary syndrome.
    Wallace KL; Johnson V; Sopelak V; Hines R
    Fertil Steril; 2011 Oct; 96(4):1051-6. PubMed ID: 21851939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Features of morphometry of ultrasound and endometrial histology in the anovulatory polycystic ovary syndrome women].
    Zhang EH; Liang XY; DU J; Li SP; Hu RD; Xu YW; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):380-3. PubMed ID: 16831358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
    Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.
    Hutchison SK; Stepto NK; Harrison CL; Moran LJ; Strauss BJ; Teede HJ
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E48-56. PubMed ID: 20926534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.